Skip to main content

Table 2 Baseline characteristics of apparently healthy young men in northwest Nicaragua stratified by trajectories of a future decline in kidney function using gold standard measurements (CKDEPI Creat/Cyst eGFR) (n = 263)

From: Identification of young adults at risk of an accelerated loss of kidney function in an area affected by Mesoamerican nephropathy

Trajectories of the decline in kidney function

N

Age at baseline (Mean; SD)

Serum creatinine level at baseline‡ (Median; IQR)

eGFRScr at baseline‡ (Median; IQR)

eGFRScr-Scys at baseline† (Median; IQR)

Urinary NGAL level at baseline (Median; IQR)

UACR ≥30 mg/dL at baseline (n; %)

Outdoor work at baseline (n; %)

Stable kidney function (−0.6 mL/min/1.73 m2/year)

213

23.6 ± 3.89

0.76 (0.57–0.76)

131 (124–140)

118 (108–125)

5.04 (4.7–5.4)

10 (4.7)

151 (70.9)

Rapid decline in kidney function (− 18.2 mL/min/1.73 m2/year)

25

23.3 ± 3.65

0.66 (0.47–0.76)

132 (123–152)

117 (103–124)

5.20 (5.0–5.5)

0 (0)

24 (96.0)

Renal dysfunction (− 3.8 mL/min/1.73 m2/year)

25

25.4 ± 2.97

1.23 (1.14–1.52)

80 (62–91)

56 (49–68)

5.7 (5.5–5.7)

4 (16.0)

19 (76.0)

Total

263

23.7 ± 3.82

0.76 (0.66–0.85)

129 (121–139)

116 (102–125)

5.20 (4.9–5.7)

14 (5.3)

194 (73.8)

  1. ‡Routine local test measurement. †Gold-standard outcome measured in Oxford 2 years later. Urinary biomarkers of kidney injury